Tag: bioequivalence studies
Modified-Release Bioequivalence: Special Considerations for Regulatory Approval
Explore the complex regulatory and technical considerations for bioequivalence studies of modified-release formulations, including FDA vs EMA guidelines, pharmacokinetic parameters, and development challenges.
Bioequivalence Studies: What the FDA Requires Generic Drug Manufacturers to Prove
The FDA requires generic drug makers to prove their products match brand-name drugs in how the body absorbs them. Bioequivalence studies ensure safety, effectiveness, and cost savings for millions of patients.
